01/14/2025
4:16 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
4:39 PM | Anderson Cynthia Lynn (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:40 PM | Prince Joshua S. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:28 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
3:49 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:53 PM | Nantahala Capital Management, LLC (Filed by)
Vistagen Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
09/23/2024
7:49 AM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
4:00 PM | FitzPatrick Margaret M (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
4:00 PM | Rotunno Mary L. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
4:00 PM | Cunningham Ann Michelle (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
4:00 PM | Curley Joanne (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for VTGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vistagen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
09/10/2024
4:00 PM | GIN JERRY B (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
4:00 PM | SAXE JON S (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:49 PM | Vistagen Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
3:53 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2024
6:00 PM | Vistagen Therapeutics (Filer)
| Form DEF 14A | |
07/16/2024
6:04 PM | Vistagen Therapeutics (Filer)
| Form DEFA14A | |
07/12/2024
3:27 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:34 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
5:06 PM | Singh Shawn (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:07 PM | Adler Reid G. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:08 PM | Anderson Cynthia Lynn (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:10 PM | Prince Joshua S. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:29 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
8:29 PM | Prince Joshua S. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
8:30 PM | Anderson Cynthia Lynn (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
8:30 PM | Adler Reid G. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
8:31 PM | Singh Shawn (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
6:18 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
8:52 PM | Vistagen Therapeutics (Filer)
| Form DEF 14A | |
04/05/2024
4:29 PM | Vistagen Therapeutics (Filer)
| Form PRE 14A | |
03/06/2024
5:00 PM | SAXE JON S (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:00 PM | Cunningham Ann Michelle (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:00 PM | Curley Joanne (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:00 PM | FitzPatrick Margaret M (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:00 PM | GIN JERRY B (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:00 PM | Rotunno Mary L. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
11:15 PM | Vistagen Therapeutics (Filer)
| Form EFFECT | |
02/14/2024
5:18 PM | CITADEL ADVISORS LLC (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
7:56 AM | Point72 Asset Management, L.P. (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024
5:27 PM | StemPoint Capital LP (Filed by)
Vistagen Therapeutics (Subject)
| Form SCHEDULE 13G | |
Is this Elon’s true agenda? (Ad) All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell them Click here for my report |
